DOI: 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

References

O'Sullivan C, Edgerly M, Velarde M. et al.
The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer.

J Clin Endocrinol Metab 2014;
99: 1291-1297

Download Bibliographical Data

Access:
Access:
Access: